跳到正文
原文
Beam Therapeutics· @BeamTx · X·· 13 天前AI 评分22
AI 导读

今日,Beam宣布公司将在第68届美国血液学会(ASH)年会暨博览会上以口头报告形式公布ristoglogene autogetemcel(risto-cel)BEACON 1/2期临床试验的更新数据。

正文

Today, Beam announced that the company will present updated data from the BEACON Phase 1/2 clinical trial of ristoglogene autogetemcel (risto-cel) in an oral presentation at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition.

来源:Beam Therapeutics · x.com